Literature DB >> 4175595

Pharmacologic alteration of steroid hormone functions.

R Gaunt, B G Steinetz, J J Chart.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4175595     DOI： 10.1002/cpt196895657

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  CYP17 inhibitors for prostate cancer therapy.

Authors:  Tadas S Vasaitis; Robert D Bruno; Vincent C O Njar
Journal:  J Steroid Biochem Mol Biol       Date:  2010-11-17       Impact factor: 4.292

Review 2.  Aminoglutethimide: a "side-effect" turned to therapeutic advantage.

Authors:  S W Hughss; D M Burley
Journal:  Postgrad Med J       Date:  1970-07       Impact factor: 2.401

Review 3.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 4.  Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.

Authors:  Hui Zhu; Jorge A Garcia
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

5.  Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.

Authors:  M R Robinson; B S Thomas
Journal:  Br Med J       Date:  1971-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.